PharmaVitae 2005: Genzyme Global Analysis This analysis examines the current position and future outlook for Genzyme in the biotechnology sector. ...more

Market Study July 2005

Commercial Insight: Cytotoxics - Generic Adversity Facing Major Cytotoxics There is a plethora of cytotoxics on the market but only a few dominate in terms of sales. ...more

Management Report July 2005

PharmaVitae 2005: Johnson & Johnson Global Analysis This Analysis examines the current position and future outlook for J&J in the ethical pharmaceutical ...more

Market Study July 2005

PharmaVitae 2005: Johnson & Johnson Global & US Analysis This analysis examines the current position and future outlook for J&J in the ethical pharmaceutical ...more

Management Report July 2005

PharmaVitae 2005: Shire Global Analysis This analysis examines the current position and future outlook for Shire Pharmaceuticals in the ethical ...more

Market Study July 2005

PharmaVitae 2005: Shire Global & US Analysis This analysis examines the current position and future outlook for Shire Pharmaceuticals in the ethical ...more

Market Study July 2005

Stakeholder Opinions: Primary Brain Cancer - Temozolomide Turns Heads The incidence of glioblastoma is increasing. Schering-Plough's temozolomide has gained approval as first ...more

Market Study July 2005

Evolution of Gloabl Consumer Trends There are 10 global consumer mega-trends that will determine successful NPD and marketing strategies in ...more

Market Study July 2005

Non-Volatile Memory Markets (market briefing) The worldwide non-volatile memory market is expected to be $17. ...more

Market Study July 2005

PharmaVitae 2005: Roche Global Analysis This analysis examines the current position and future outlook for Roche in the ethical pharmaceutical ...more

Market Study July 2005

Respiratory Handbook 2005-15: Novartis Moving Into the Major League The respiratory market has experienced below average growth in the last five years (CAGR, 10%) reaching ...more

Market Study June 2005

PharmaVitae 2005: Roche Global and US Analysis This analysis examines the current position and future outlook for Roche in the ethical pharmaceutical ...more

Management Report June 2005

Commercial Insight: Antidyslipidemics - Cholesterol Absorption of Lipitor's Dominance The next 10 years will see six statins lose patent protection, with the potential loss of over $20 ...more

Management Report June 2005

PharmaVitae 2005: Akzo Nobel Global & US Analysis This analysis examines the current position and future outlook for Akzo Nobel in the ethical ...more

Management Report June 2005

PharmaVitae 2005: Akzo Nobel Global Analysis This analysis examines the current position and future outlook for Akzo Nobel in the ethical ...more

Market Study June 2005

The eHealth Market in Germany: Assessing the Online Needs of Physicians and Consumers (market briefing) The eHealth market in Germany, driven by patients' and physicians' demands for online services, and by ...more

Market Study June 2005